1049436

Ajanta Pharma USA Inc — FEI 3010721419

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 4, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Bridgewater, NJ (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)